References
- Stumvoll M, Haring HU. Glitazones: clinical effects and molecular mechanisms. Ann Med 2002;34:217–24
- Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Int Med 2003;3:25–33
- DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Int Med 1999; 131:281–303
- Miyazaki Y, Mahankali A, Matsuda M, et al. Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care 2001;224:710–19
- DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;3:E214–23
- Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;237: E214–E223
- Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000;85:4426–29
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–19
- Rudenski AS, Matthews DR, Levy JC, Turner RC. Understanding ‘insulin resistance’: both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 1991;40:908–17
- Levy JC, Matthews DR, Hermans MP. Correct Homeostasis Model Assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191–92
- Katz A, Nambi SS, Mather K, et al. Quantitative Insulin Check Index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402–10
- Katsuki A, Sumida Y, Gabazza EC, et al. QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2002;87:2906–8
- Yokoyama H, Emoto M, Fujiwara K, et al. Quantitative insulin sensitivity check index and the reciprocal index of Homeostasis Model Assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care 2003;26:2426–32
- Aronoff S, Rosenblatt S, Braithwaite S, et al. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes. Diabetes Care 2000;23:1605–11
- Kipnes MS, Krosnick A, Rendell MS, et al. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, placebo-controlled study. Am J Med 2001;111:10–17
- Einhorn D, Rendell M, Rosenzweig J, et al. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. Clin Ther 2000;22:1395–409
- National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039–57
- Steel RGD, Torrie JH. Principles and procedures of statistics. New York: McGraw-Hill Book Company; 1960
- Miyazaki Y, Matsuda M, DeFronzo RA. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care 2002;25: 517–23
- Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–70
- Bonora E, Targher G, Alberiche M, et al. Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000;23:57–63
- Perseghin G, Caumo A, Caloni M, et al. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 86:4776–81
- Katsuki, A, Sumida Y, Gabazza EC, et al. Homeostasis Model Assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001;24:362–5
- Haffner SM, Gonzales C, Miettinen H, et al. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 1996;19:1138–41
- Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care;1997:20:1087–92
- Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001;86:5457–64
- Pavo I, Jermendy G, Varkonyi TT, et al. Effect of Pioglitazone Compared with Metformin on Glycemic Control and Indicators of Insulin Sensitivity in Recently Diagnosed Patients with Type 2 Diabetes. J Clin Endocrinol Metab 2003;88:1637–45